MRI与PET/CT在新诊断前列腺癌初始分期中的系统综述
该系统综述纳入2012至2020年间139项研究,评估MRI和/或PET/CT对新诊断前列腺癌TNM分期的价值。T和N分期因数据异质性、样本量小和事件率低导致敏感性范围广泛、不确定性高;M分期中PSMA-PET/CT表现优于传统影像。
要点
- MRI主要用于T分期,PET/CT主要用于N和M分期。
- T和N分期敏感性范围广泛,数据异质性和不确定性高。
- PSMA-PET/CT在M分期中表现优于传统影像。
核心结论
- 新诊断前列腺癌现代影像TNM分期的研究多样,但T和N分期数据异质性和不确定性高,需标准化。
- PSMA-PET/CT是M分期最有前景的技术,近期已在随机对照试验中评估。
研究设计与样本
- 系统综述,检索MEDLINE和Web of Science数据库2012至2020年间文献,遵循PRISMA指南。
- 共纳入139项研究:83项关于T分期,47项关于N分期,24项关于M分期。
主要发现
- T分期研究多评估MRI,PET/CT主要用于N和M分期。
- 检测前列腺外侵犯、精囊侵犯或淋巴结侵犯的敏感性范围广泛。
- 影像纳入现有风险工具时,部分研究观察到准确性提升,但未被重复验证。
- M分期中PSMA-PET/CT表现显著优于传统影像。
临床怎么用
- T和N分期影像选择需考虑数据局限性,PSMA-PET/CT可用于M分期评估。
局限性
- 数据异质性、样本量小和事件率低导致置信区间大和高不确定性。
- 多数研究为回顾性,仅1项随机对照试验。
- 影像纳入风险工具的准确性提升未被重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Management of newly diagnosed prostate cancer (PCa) is guided in part by accurate clinical staging. The role of imaging, including magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT), in initial staging remains controversial. OBJECTIVE: To systematically review the studies of MRI and/or PET/CT in the staging of newly diagnosed PCa with respect to tumor (T), nodal (N), and metastatic (M) staging (TNM staging). EVIDENCE ACQUISITION: We performed a systematic review of the literature using MEDLINE and Web of Science databases between 2012 and 2020 following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement guidelines. EVIDENCE SYNTHESIS: A total of 139 studies (83 on T, 47 on N, and 24 on M status) were included. Ninety-nine (71%) were retrospective, 39 (28%) were prospective, and one was a randomized controlled trial (RCT). Most studies on T staging examined MRI, while PET/CT was used primarily for N and M staging. Sensitivity for the detection of extraprostatic extension, seminal vesicle invasion, or lymph node invasion ranged widely. When imaging was incorporated into existing risk tools, gain in accuracy was observed in some studies, although these findings have not been replicated. For M staging, most favorable results were reported for prostate-specific membrane antigen (PSMA) PET/CT, which demonstrated significantly better performance than conventional imaging. CONCLUSIONS: A variety of studies on modern imaging techniques for TNM staging in newly diagnosed PCa exist. For T and N staging, reported sensitivity of imaging modalities such as MRI or PET/CT varied widely due to data heterogeneity, small sample size, and low event rates resulting in large confidence intervals and a high level of uncertainty. Therefore, uniformity in data presentation and standardization on this topic are needed. The most promising technique for M staging, which was evaluated recently in an RCT, is PSMA-PET/CT. PATIENT SUMMARY: We performed a systematic review of currently available imaging modalities to stage newly diagnosed prostate cancer. With respect to local tumor and lymph node assessment, performance of imaging ranged widely. However, prostate-specific membrane antigen positron emission tomography/computed tomography showed favorable results for the detection of distant metastases.
引用
- Abrams-Pompe RS, Fanti S, Schoots IG, et al. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature. Eur Urol Oncol. 2020. PMID: 33272865. doi:10.1016/j.euo.2020.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。